Valueworks LLC Gilead Sciences, Inc. Transaction History

Valueworks LLC

$322 Million
Q2 2024

A detailed history of Valueworks LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Valueworks LLC holds 29,047 shares of GILD stock, worth $2.43 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

29,047

Previous 28,897 0.52%

Holding current value

$2.43 Million

Previous $2.12 Million 5.81%

% of portfolio

0.62%

Previous 0.69%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $9,472 - $10,932	150 Added 0.52%	29,047 $1.99 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $10,737 - $13,093	-150 Reduced 0.52%	28,897 $2.12 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $6,667 - $7,561	-91 Reduced 0.31%	29,047 $2.35 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $149,284 - $162,872	-2,019 Reduced 6.48%	29,138 $2.18 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $31,848 - $36,327	-419 Reduced 1.33%	31,157 $2.4 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $2,937 - $3,347	38 Added 0.12%	31,576 $2.62 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $563,996 - $809,703	-9,050 Reduced 22.3%	31,538 $2.71 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $5,120 - $5,848	86 Added 0.21%	40,588 $2.5 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $25,512 - $28,734	442 Added 1.1%	40,502 $2.5 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $22,067 - $27,652	-381 Reduced 0.94%	40,060 $2.38 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $8,045 - $9,131	-124 Reduced 0.31%	40,441 $2.94 Million
Q3 2021 Oct 19, 2021	BUY	$67.69 - $73.03 $67 - $73	1 Added 0.0%	40,565 $2.83 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $49,252 - $53,815	776 Added 1.95%	40,564 $2.79 Million
Q1 2021 May 25, 2021	BUY	$60.0 - $68.46 $3,120 - $3,559	52 Added 0.13%	39,788 $2.57 Million
Q4 2020 Feb 24, 2021	SELL	$56.65 - $64.55 $110,184 - $125,549	-1,945 Reduced 4.67%	39,736 $2.32 Million
Q3 2020 Nov 17, 2020	SELL	$62.1 - $78.08 $707,629 - $889,721	-11,395 Reduced 21.47%	41,681 $2.63 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $748,719 - $869,400	-10,350 Reduced 16.32%	53,076 $4.08 Million
Q1 2020 May 19, 2020	SELL	$62.63 - $80.22 $1.95 Million - $2.5 Million	-31,162 Reduced 32.94%	63,426 $4.74 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $297 Million - $327 Million	-4,824,412 Reduced 98.08%	94,588 $6.15 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $299 Million - $329 Million	4,856,556 Added 7777.46%	4,919,000 $6.15 Million
Q3 2019 Nov 18, 2019	SELL	$62.51 - $69.0 $453,134 - $500,181	-7,249 Reduced 10.4%	62,444 $3.96 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $516,428 - $579,114	8,347 Added 13.61%	69,693 $4.71 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $247,306 - $277,047	3,955 Added 6.89%	61,346 $3.99 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $586,027 - $764,720	-9,680 Reduced 14.43%	57,391 $35.9 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $201,080 - $222,633	-2,821 Reduced 4.04%	67,071 $5.18 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $4.53 Million - $5.29 Million	69,892 New	69,892 $4.95 Million
Q1 2018 May 17, 2018	SELL	$72.84 - $88.8 $5.07 Million - $6.18 Million	-69,581 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $165,566 - $194,351	-2,327 Reduced 3.24%	69,581 $4.99 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $31,007 - $36,752	430 Added 0.6%	71,908 $5.83 Million
Q2 2017 Aug 15, 2017	BUY	N/A	71,478	71,478 $5.06 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valueworks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valueworks LLC with notifications on news.

Account